Acquisition Announced Sponsor buyer
SV Health Investors acquisition of EpiVax
Announced 2 Apr 2026
Advisers
EpiVax
Target
Not disclosed
SV Health Investors
Acquirer
- Legal adviser
- Target
- EpiVax
- Acquirer
- SV Health Investors
- Target based in
- United States
- Buyer based in
- United States
- Sector
- Pharma Services
- Tags
- Pharma Services, Life Sciences, Clinical Trial Services
In the league tables
Similar deals
- Everest Clinical Research acquisition of Firma Data Services Sep 2026 · Clinical Trial Services
- McKesson acquisition of Precision Medicine Group Aug 2026 · US$2.3bn · Clinical Trial Services
- THL Partners acquisition of Celerion Apr 2026 · Pharma Services
- Webster Equity Partners acquisition of Lifecore Biomedical Sep 2026 · US$664m · Pharma Services
- Labcorp acquisition of MLM Medical Labs Sep 2026 · Clinical Trial Services
Sources
- 2 Apr 2026 Morgan Lewis Advises SV Health Investors on EpiVax Acquisition morganlewis.com
